col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


41 Ergebisse       Seite 1

 [1] 
Federal Medical Biological Agency: Medicine of Extreme Situations
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jul―19 Changes in some immunological parameters after COVID-19: general trends and individual characteristics TV Glazanova, ER Shilova, YS Efremova, JB Chubukina, SS Bessmeltsev
2 [GO] 2024―Jan―22 The specifics of encephalitis after COVID-19 MP Bobrov, VB Voitenkov, EV Ekusheva, ES Kiparisova
3 [GO] 2024―Jan―22 Patterns of acute chemical poisonings in a metropolis against the background of the COVID-19 pandemic in 2020-2021 SA Solonin, MV Belova, NE Tereshkina, EA Kasholkina, IA Tyurin, MA Godkov, MM Potskhveriya
4 [GO] 2023―Okt―10 Heart disease in young elite athletes having a history of COVID-19 LM Makarov, VN Komolyatova, II Kiselyova, DA Besportochny, AG Akopyan, AV Dmitrieva, NV Aksenova
5 [GO] 2023―Okt―10 Current understanding of epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children YuE Konstantinova, AA Vilnits, MK Bekhtereva, LA Alekseeva, OS Glotov, ES Egorova
6 [GO] 2023―Jul―21 Particularities of curation of athletes with protracted course of COVID-19 LA Balykova, AV Zholinsky, MS Tarasova, SA Ivyanskiy, SA Bazanovich, MV Shirmankina, et al. (+4)
7 [GO] 2023―Mrz―06 Results of epidemiological surveillance for COVID-19 among students and teaching staff of the University SA Sayganov, AV Liubimova, IM Gasanbekov, AV Meltser, ZV Lopatin, BI Aslanov
8 [GO] 2023―Jan―16 Neutralizing antibody creation technologies: case of SARS-CoV-2 VP Baklaushev, EM Samoilova, SM Kuznetsova, EV Ermolaeva, GM Yusubalieva, VA Kalsin, et al. (+2)
9 [GO] 2022―Dez―27 Assessment of cytotoxicity and antiviral activity against SARS-CoV-2 of the mixture of lactoferrin, artemisinin, and azithromycin in vitro AA Ryabchenkova, VV Kopat, ER Chirak, EL Chirak, IA Leneva, EA Glubokova, et al. (+3)
10 [GO] 2022―Okt―02 N protein based vaccine against SARS-CoV-2 produces a strong T cell immune response to N Protein of novel strains SO Rabdano, VE Mukhin, VV Makarov, GO Rudakov, EA Ruzanova, SA Arakelov, et al. (+7)
11 [GO] 2022―Jun―17 Dynamics of humoral immunity to SARS-CoV-2 in the professionally homogeneous group of people over a two-year period of COVID-19 outbreak VG Pomelova, TA Bychenkova, NI Bekman, NS Osin, YuN Ishkov, KK Styazhkin
12 [GO] 2022―Mai―26 Neurophysiological assessment of speech function in individuals having a history of mild COVID-19 SA Gulyaev, YuA Voronkova, TA Abramova, EA Kovrazhkina
13 [GO] 2022―Mai―26 Primary pre-hospital triage of patients with COVID-19 MA Cherkashin, NS Berezin, NA Berezina, AA Nikolaev, DI Kuplevatskaya, VI Kuplevatsky, et al. (+2)
14 [GO] 2022―Mai―12 Liver damage in patients with COVID-19 DA Vologzhanin, AS Golota, TA Kamilova, SV Makarenko, SG Scherbak
15 [GO] 2022―Mai―12 Evaluation of the impact of COVID-19 pandemic on overall mortality in Ozyorsk urban district MV Osipov, VA Sokolova, AS Kushnir
16 [GO] 2022―Feb―10 Development of PCR test for detection of the SARS-CoV-2 genetic variants alpha, beta, gamma, delta GA Shipulin, YuA Savochkina, AK Shuryaeva, EE Shivlyagina, AO Nosova, EE Davydova, et al. (+3)
17 [GO] 2021―Sep―30 Experimental and clinical evaluation of mefloquine effectiveness against the infection caused by SARS-CoV-2 KN Filin, VD Gladkikh, VN Bykov
18 [GO] 2021―Sep―17 Respiratory muscle strength in patients after COVID-19 OI Savushkina, MM Malashenko, AV Cherniak, EV Krjukov, EA Sinitsyn, KA Zykov
19 [GO] 2021―Jun―30 Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection YuV Lobzin, AN Uskov, NV Skripchenko, AA Vilnits, MK Bekhtereva, IV Babachenko
20 [GO] 2021―Jun―30 Method for quantitative assessment of protective immunity against SARS-CoV-2, its duration and antibody dynamics AM Karmishin, NYu Nosov, VB Postupailo, BA Zhigarlovskiy, AA Kruglov, AN Petukhov
21 [GO] 2021―Jun―19 Evaluation of efficacy of the amino acid-peptide complex administered intragastrically to golden hamsters experimentally infected with SARS-CoV-2 DS Laptev, GA Protasova, SG Petunov, AS Radilov, SV Chepur, AS Gogolevskiy, et al. (+3)
22 [GO] 2021―Feb―16 Epidemiological characteristics of community-acquired pneumonia during the COVID-19 epidemic in the Russian Federation BA Zhigarlovskiy, NF Nikityuk, VB Postupailo, AA Goryaev, EV Belov, NYu Nosov, et al. (+3)
23 [GO] 2020―Dez―20 Dynamics and logic of COVID-19 containment measures YuV Raskina, AA Novkunskaya, AA Barchuk
24 [GO] 2020―Dez―20 Endothelial dysfunction in COVID-19 patients and clinical application of laser therapy AV Kochetkov, NYu Ponomareva, NG Kadnikova, VG Mitkovskij, EN Yampolskaya, VV Lazarev
25 [GO] 2020―Dez―14 Effectiveness of immobilized probiotics for complex therapy of novel coronavirus infection COVID-19 in hospital settings NG Bomshteyn, YuV Bolotov, IA Kim, DV Trukhin
26 [GO] 2020―Dez―13 Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents DS Laptev, SG Petunov, OV Nechaykina, DV Bobkov, AS Radilov
27 [GO] 2020―Dez―03 Surgical care arrangement at the general hospital during the COVID-19 pandemic YaA Nakatis, VA Ratnikov, VA Kashchenko, AV Lodygin, AI Mitsinskaya, MA Mitsinskii, AD Akhmetov
28 [GO] 2020―Dez―02 Sars-CoV-2 in the context of coronaviruses and animal models of COVID-19 AA Korenkova, VV Bahmetjev, KS Gorbunov
29 [GO] 2020―Nov―30 COVID-19 in ophthalmic practice KhP Takhchidi, NKh Takhchidi, MKh Movsesian
30 [GO] 2020―Aug―19 Development of the kit for diagnostics of COVID-19 by real time RT-PCR AK Shuryaeva, TV Malova, EE Davydova, YuA Savochkina, EV Bogoslovskaya, RR Mintaev, et al. (+6)
31 [GO] 2020―Aug―19 Inobvious pathogenetic links of mechanisms effects on the human organism of the SARS-CoV-2 virus IB Ushakov, AN Parfyonov, RA Bondarenko, VN Komarevtsev
32 [GO] 2020―Aug―18 Hyperbaric oxygen therapy in treatment of COVID-19 complicated cases: first application experience review ED Mozgovoy, YuD Udalov, MV Ochkolias
33 [GO] 2020―Aug―18 Study of the effectiveness of methylprednisolone at different stages of inpatient care for patients with pneumonia caused by a new COVID-19 coronavirus infection EE Arinina, RT Tairova, AB Berdalin, SS Gujev, NA Glotova, YuV Rubleva, et al. (+4)
34 [GO] 2020―Aug―17 Medical evacuation of patients COVID-19 NN Baranova, AV Akin'shin, SF Goncharov, MA Meshkov, KM Zelentsov, VP Pys'mennij
35 [GO] 2020―Aug―17 Countermeasures against the introduction and spread of coronavirus infection COVID-19 in medical organizations VV Nikiforov, TG Suranova, VN Komarevtsev, SYu Khlutkov, VI Skvortsova
36 [GO] 2020―Aug―10 Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2 KN Filin, IA Berzin, VN Bykov, VD Gladkikh, SYa Loginova, SV Savenko, VN Schukina
37 [GO] 2020―Aug―08 Actual problems of psychological support of healthcare workers in infectious hospitals for patients with COVID-19 in the territory of the Krasnoyarsk region MS Sevostyanova, NV Selezneva, PA Chernomurova, ZS Kharchenko, KV Glushkova, AO Fetisov, et al. (+2)
38 [GO] 2020―Jul―30 Genetic determinants of the response to coronavirus infection COVID-19 SV Poyarkov, VV Makarov, SA Kraevoy, SM Yudin
39 [GO] 2020―Jul―30 Effect of physical activity level on the course of pneumonia caused by COVID-19 AS Samoylov, YuD Udalov, SE Nazaryan, AV Naikina
40 [GO] 2020―Jul―29 Justification of the possible directions of pathogenetic therapy of a new coronavirus infection YuV Lobzin, MB Ivanov, EB Shustov, VL Rejnyuk, AV Fomichev, AE Sosyukin, BS Litvincev
41 [GO] 2020―Jul―29 Clinical and epidemiological features of the new coronavirus infection COVID 19 in the central black region IE Esaulenko, VI Popov, TN Petrova, AYu Goncharov
 [1] 

41 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec